Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Sales Teleselling > Why Did Telemarketing Die?

Tags

  • drugs
  • dinner
  • product
  • combination products
  • companies involved

  • Links

  • Weight Loss - Don't Make Losing Weight Harder Than It Has To Be
  • Electronic Contract Manufacturing
  • To Have A Bankruptcy Lawyer Or Not To Have A Bankruptcy Lawyer
  • Digg It - Why Did Telemarketing Die?

    Have you ever considered why a business advertising model like telemarketing die
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    d? Sure we know that the Senate and US Congress Passed a Bill for Do Not Call Li
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ts and that the President of the United States signed it into law right? And we
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    now that the Federal Trade Commission fined a few companies a lot of money and l
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ke FAX Marketing; telemarketing died on the vine. But why did this happen?

    Well
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    , telemarketing became too efficient and too many companies hired too many firms
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    to cold call targeted lists and often random phone numbers too. Some marketing c
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    nsultants who have written books on the subject say that it conflicted with peop
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    e’s lives; such as phone calls at dinner time and actually turned off customers
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    and it did not really help folks get the information in the way they needed at t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e appropriate time to assist them in their decision making process for the produ
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    t or service.

    In fact many of us have simply been very upset by pushy telemarke
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ers calling at our dinner hour. When you are busy and not interested they waste
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    your time and will not take no for an answer and some of these persuasive folks
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ndeed are paid commission and try every manipulative trick in the book. It is fo
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    these reasons telemarketing lost favor and indeed has been literally slaughtere
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    .

    The few companies remaining due to bogus government regulations due to lobbyi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    sts are extremely careful now how they do things because people, customers and c
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    nsumers no longer accept these intrusions. They no longer consider it advertisin
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    , but rather more liken it to International Terrorism. Consider all this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/39111/diggit-Why-Did-Telemarketing-Die.html">Why Did Telemarketing Die?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/39111/diggit-Why-Did-Telemarketing-Die.html]Why Did Telemarketing Die?[/url]

    Related Articles:

    What Cleaning Companies Need to Know About Mold

    Call Center Intelligence

    Out of Control?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com